Twelve‐week secukinumab treatment is consistently efficacious for moderate‐to‐severe psoriasis regardless of prior biologic and non‐biologic systemic treatment: Post hoc analysis of six randomised trials-Reference-Cited by-同舟云学术

Twelve‐week secukinumab treatment is consistently efficacious for moderate‐to‐severe psoriasis regardless of prior biologic and non‐biologic systemic treatment: Post hoc analysis of six randomised trials

Published:2021-02-09 Issue:4 Volume:35 Page:928-937
ISSN:0926-9959
Container-title:Journal of the European Academy of Dermatology and Venereology
language:en
Short-container-title:J Eur Acad Dermatol Venereol

Author:

Hampton P.¹,Halliday A.²^ORCID,Aassi M.³,Subramanian S.⁴^ORCID,Jain M.⁴,Griffiths C.E.M.⁵

Affiliation:

1. Newcastle Dermatology Newcastle Hospitals NHS Trust Newcastle Upon Tyne UK

2. Novartis Pharmaceuticals UK Limited Surrey UK

3. Novartis Pharma AG Basel Switzerland

4. Novartis Healthcare Pvt. Ltd Hyderabad India

5. Centre for Dermatology The University of Manchester and NIHR Manchester Biomedical Research Centre Manchester UK

Funder

Novartis Pharmaceuticals UK Limited

Publisher

Wiley

Subject

Infectious Diseases,Dermatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jdv.16982

Reference31 articles.

1. Global Psoriasis Atlas.2019. URLhttps://globalpsoriasisatlas.org/[updated 2019.] (last accessed: 06 November 2020).

2. The Burden of Moderate to Severe Psoriasis

3. The Risk of Mortality in Patients With Psoriasis

4. Systemic pharmacological treatments for chronic plaque psoriasis: a network meta‐analysis;Sbidian E;Cochrane Database Syst Rev,2017

5. National Institute for Health and Care Excellence (NICE).Psoriasis: assessment and management (Clinical Guideline 153).2012. URLhttps://www.nice.org.uk/guidance/CG153/chapter/1‐Guidance(last accessed: 06 November 2020).

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Psoriatic arthritis, biologic therapy experience, body mass index, and onset age of psoriasis were independent factors of secukinumab discontinuation in patients with psoriasis;Expert Review of Clinical Pharmacology;2024-07-12

2. A systematic review of 454 randomized controlled trials using the Dermatology Life Quality Index: experience in 69 diseases and 43 countries;British Journal of Dermatology;2023-03-27

3. Onset of Plaque Psoriasis Treatment Responses With Anti IL-17/IL-23 Biologic Therapies;J DRUGS DERMATOL;2022

4. Assessment of efficacy and safety of UV-based therapy for psoriasis: a network meta-analysis of randomized controlled trials;Annals of Medicine;2022-01-06